Morgan Stanley Novo Nordisk A S Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Novo Nordisk A S stock. As of the latest transaction made, Morgan Stanley holds 12,319,787 shares of NVO stock, worth $804 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
12,319,787
Previous 12,204,292
0.95%
Holding current value
$804 Million
Previous $1.05 Billion
18.51%
% of portfolio
0.06%
Previous 0.08%
Shares
23 transactions
Others Institutions Holding NVO
# of Institutions
1,762Shares Held
340MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.23 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$966 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$809 Million1.24% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$775 Million0.36% of portfolio
-
Fayez Sarofim & CO Houston, TX11.2MShares$732 Million2.01% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $147B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...